About Products Value to Hospital Patients Resources News Contact Us ETHICS OVERVIEW ETHICS PATENTS Code of Business Conduct and Ethics Cardiva Medical, Inc.’s management and employees are dedicated to high ethical standards and recognize the Company’s duty to conduct its affairs within the bounds of the law. The Company has formalized certain business policies and practices in this Code of Business Conduct and Ethics. The Code of Conduct is designed to ensure that the Company and its employees and agents are in compliance with all applicable laws and regulations concerning good engineering, clinical, manufacturing, laboratory, regulatory, labeling, sales and marketing activities, third-party reimbursement of the cost of its products, human resources and environmental practices. Cardiva Company Milestones VASCADE MVP® receives FDA approval for 6-12F Inner Diameter (ID) multi-vessel venous vascular closure Antegrade Study results published in Vascular Disease Management in 2018 VASCADE® receives FDA approval for use in femoral veins in 2018 VASCADE VCS approved by the FDA in 2013 VASCADE VCS approved for CE Mark in Europe in 2012 CATALYST III received 510(k) clearance in 2009 CATALYST II approved for CE Mark in Europe in 2008 CATALYST II received 510(k) clearance in 2007 About Us Products Value to Hospital Patients Resources News Contact Us IFUs © 2021 Cardival Medical, Inc. VASCADE®, VASCADE MVP®, and Cardiva CATALYST® are registered trademarks of Cardiva Medical, Inc.. Document Portal Privacy Policy Site Map